Welcome to our dedicated page for Everpure SEC filings (Ticker: P), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Everpure, Inc. filings document corporate governance, shareholder voting matters, executive compensation, equity awards, and public-company reporting topics. The company's DEF 14A proxy statement includes disclosures tied to annual meeting matters, compensation tables, equity award values, vesting information, and governance oversight.
Everpure's regulatory record also supports disclosure around its operating company status, single reportable segment, capital and equity-compensation matters, and risk and governance subjects associated with a public technology company.
Everpure, Inc. director and Chief Visionary Officer John Colgrove reported open-market sales totaling 100,000 shares of Class A Common Stock on June 10 and June 12, 2026. The trades were executed at weighted average prices around $70–$72 per share.
The sales were made by family trusts, including The RWC Irrevocable Trust, The EEC Irrevocable Trust, and the Colgrove Family Living Trust, rather than by Colgrove personally. They were carried out under a Rule 10b5-1 trading plan adopted on January 8, 2026 on behalf of the applicable trust.
After the reported transactions, the filing shows 6,614,941 shares held directly and 467,694 shares held indirectly by trust, indicating that the net sale represents a relatively small portion of the overall disclosed position.
The issuer disclosed proposed sales of Common shares via Form 144, reporting multiple 10b5-1 plan transactions by related trusts. The filing lists a Founders Shares block of 50,000 shares and multiple executed plan sales dated between 04/21/2026 and 06/10/2026, with per‑trade share counts and gross proceeds shown for each trade.
P submitted a Form 144 notice through Morgan Stanley Smith Barney LLC to sell 49,900 shares of Common Stock on the NYSE. The filing lists multiple Rule 10b5-1 sales executed on various dates. Examples include 100,000 shares sold by THE COLGROVE FAM CHARITABLE REM TRU on 05/11/2026 and 50,000 shares sold by THE EEC TRUST on 05/11/2026.
Yen Mallun reported acquisition or exercise transactions in this Form 4 filing.
Everpure, Inc. director Yen Mallun reported an equity award of 3,515 shares of Class A Common Stock, granted at no cash cost as a Restricted Stock Unit (RSU) award. All RSU shares are scheduled to vest on June 10, 2027, conditioned on continued board service.
The award provides for accelerated vesting immediately before a Change in Control or Corporate Transaction, if Mallun remains in Continuous Service on that effective date. If Mallun voluntarily resigns as a director, a pro-rated portion of the RSU will vest based on days served between grant and resignation. Following this grant, Mallun directly holds 48,016 Class A shares.
Tomb Gregory reported acquisition or exercise transactions in this Form 4 filing.
Everpure, Inc. director Tomb Gregory reported an equity compensation grant in the form of Restricted Stock Units tied to Class A Common Stock. The award covers 3,515 shares at no purchase price and will increase his direct holdings to 34,655 shares after settlement.
All 3,515 shares underlying the Restricted Stock Unit award are scheduled to vest on June 10, 2027, if Gregory remains in Continuous Service as defined in the company’s 2015 Equity Incentive Plan. If he voluntarily resigns as a director before that date, a pro rata portion will vest based on days served.
The award is also subject to accelerated vesting in the event of a Change in Control or Corporate Transaction under the plan. In that case, the shares subject to the award fully vest immediately before the transaction becomes effective, provided he remains in Continuous Service on that effective date.
Murphy John Francis reported acquisition or exercise transactions in this Form 4 filing.
Everpure, Inc. director John Francis Murphy received an award covering 3,515 shares of Class A Common Stock in the form of Restricted Stock Units. These units were granted at no cash cost and will be settled in shares when they vest.
According to the award terms, 100% of the 3,515 shares are scheduled to vest on June 10, 2027, provided Murphy maintains Continuous Service as defined in Everpure’s 2015 Equity Incentive Plan. If he voluntarily resigns as a director before that date, a pro rata portion vests based on days served. The award will also fully vest immediately before a qualifying Change in Control or Corporate Transaction, subject to his continued service. Following this grant, Murphy holds 19,183 shares of Class A Common Stock directly.
Brown Andrew William Fraser reported acquisition or exercise transactions in this Form 4 filing.
Everpure, Inc. director Brown Andrew William Fraser reported an equity compensation grant and updated holdings in Class A Common Stock. He received a grant of 3,515 Restricted Stock Units (RSUs) at no cash cost, increasing his direct ownership to 32,418 shares after the award.
The RSUs represent shares to be issued when they vest. According to the terms, 100% of the RSUs vest on June 10, 2027, provided he remains in continuous service. Vesting accelerates in full immediately before a Change in Control or Corporate Transaction as defined in Everpure’s 2015 Equity Incentive Plan.
The filing also notes 1,500 shares of Class A Common Stock held indirectly by the Nicholas Brown 2021 Gift Trust. These trust-held shares are reported as indirect ownership and are separate from his directly held shares.
Taylor Susan J.S. reported acquisition or exercise transactions in this Form 4 filing.
Everpure, Inc. director Taylor Susan J.S. received a grant of 3,515 shares of Class A Common Stock in the form of a restricted stock unit award. These shares vest 100% on June 10, 2027, with provisions for accelerated vesting upon a Change in Control or certain resignation scenarios.
Everpure, Inc. director Taylor Roxanne reported a grant of 3,515 shares of Class A Common Stock underlying a Restricted Stock Unit award at no cost. These shares are to be acquired when the award vests, with 100% of the units scheduled to vest on June 10, 2027, if she remains in continuous service. The award includes accelerated vesting upon a Change in Control or Corporate Transaction and provides pro-rata vesting if she voluntarily resigns as a director before that date, based on days served. Following this grant, her reported Class A Common Stock holdings total 19,858 shares.
Rothschild Jeffrey reported acquisition or exercise transactions in this Form 4 filing.
Everpure, Inc. director Jeffrey Rothschild received a grant of 3,515 Restricted Stock Units tied to Class A Common Stock as equity compensation, with no cash price per share. The award increases his directly held position to 110,988 shares after the reported transaction.
All RSUs are scheduled to vest on June 10, 2027, subject to his continued service. The award provides for full accelerated vesting immediately before a Change in Control or Corporate Transaction, and pro-rated vesting if he voluntarily resigns based on days of service from grant to resignation.